Product NDC: | 63739-809 |
Proprietary Name: | Gabapentin |
Non Proprietary Name: | Gabapentin |
Active Ingredient(s): | 300 mg/1 & nbsp; Gabapentin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-809 |
Labeler Name: | McKesson Packaging Services a business unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075350 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121029 |
Package NDC: | 63739-809-43 |
Package Description: | 90 CAPSULE in 1 BOTTLE (63739-809-43) |
NDC Code | 63739-809-43 |
Proprietary Name | Gabapentin |
Package Description | 90 CAPSULE in 1 BOTTLE (63739-809-43) |
Product NDC | 63739-809 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Gabapentin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20121029 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services a business unit of McKesson Corporation |
Substance Name | GABAPENTIN |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |